Загрузка...
The heterogeneity of the kinetics of response to ipilimumab in metastatic melanoma: patient cases
Cytotoxic T lymphocyte antigen-4 (CTLA-4) is a negative regulator of T-cell mediated immune responses and is the target of new anti-tumor immunotherapy strategies. Ipilimumab is a fully human, antagonistic monoclonal antibody directed against CTLA-4. Results from preclinical and early clinical trial...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Academy of Cancer
Immunology
2008
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2935787/ https://ncbi.nlm.nih.gov/pubmed/18198818 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|